Catalent Inc (NASDAQ:CTLT) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a report released on Wednesday.

Several other equities analysts have also issued reports on the stock. Bank of America Corporation reiterated a “buy” rating and set a $38.00 target price (up from $37.00) on shares of Catalent in a report on Friday, July 21st. Zacks Investment Research raised shares of Catalent from a “sell” rating to a “buy” rating and set a $39.00 price target for the company in a research report on Tuesday, July 4th. William Blair raised shares of Catalent from a “market perform” rating to an “outperform” rating in a research report on Monday, May 15th. Finally, TheStreet raised shares of Catalent from a “c” rating to a “b-” rating in a research report on Wednesday, April 19th. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $32.00.

Shares of Catalent (NASDAQ CTLT) traded down 0.34% during mid-day trading on Wednesday, reaching $35.19. The company had a trading volume of 58,061 shares. The company has a market capitalization of $4.40 billion and a P/E ratio of 41.45. Catalent has a 12-month low of $21.83 and a 12-month high of $38.73. The firm has a 50-day moving average of $35.24 and a 200-day moving average of $32.01.

ILLEGAL ACTIVITY NOTICE: “Catalent Inc (CTLT) Stock Rating Upgraded by BidaskClub” was published by Watch List News and is owned by of Watch List News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.watchlistnews.com/catalent-inc-ctlt-stock-rating-upgraded-by-bidaskclub/1494861.html.

In other Catalent news, SVP Christine Dolan sold 745 shares of the company’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $34.85, for a total value of $25,963.25. The sale was disclosed in a filing with the SEC, which is available through this link.

Institutional investors have recently modified their holdings of the company. Flinton Capital Management LLC increased its position in shares of Catalent by 17.7% in the first quarter. Flinton Capital Management LLC now owns 3,616 shares of the company’s stock worth $102,000 after buying an additional 544 shares in the last quarter. Acrospire Investment Management LLC increased its position in shares of Catalent by 72.2% in the second quarter. Acrospire Investment Management LLC now owns 3,100 shares of the company’s stock worth $109,000 after buying an additional 1,300 shares in the last quarter. Quantbot Technologies LP increased its position in shares of Catalent by 110.7% in the second quarter. Quantbot Technologies LP now owns 3,434 shares of the company’s stock worth $120,000 after buying an additional 1,804 shares in the last quarter. Meadow Creek Investment Management LLC increased its position in shares of Catalent by 17.7% in the first quarter. Meadow Creek Investment Management LLC now owns 4,972 shares of the company’s stock worth $141,000 after buying an additional 748 shares in the last quarter. Finally, Acadian Asset Management LLC increased its position in shares of Catalent by 115.7% in the first quarter. Acadian Asset Management LLC now owns 5,847 shares of the company’s stock worth $166,000 after buying an additional 3,136 shares in the last quarter.

Catalent Company Profile

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Analyst Recommendations for Catalent (NASDAQ:CTLT)

Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.